Tempus @TempusAI
Tempus is a technology company leading the adoption of #AI to advance precision medicine. tempus.com Chicago, IL Joined October 2015-
Tweets1K
-
Followers15K
-
Following1K
-
Likes2K
Tempus researchers sought to investigate how PRAME expression levels correlate with real-world survival outcomes when patients are treated with a combination of immunotherapy and chemotherapy in the first-line setting. Explore the analysis and its results in the Lens Library now: tempus.co/4u7wycB
Lines of therapy are a key anchor for benchmarking therapy performance and informing R&D strategy, including when comparing patient outcomes and drug effectiveness over time and across cohorts. In a new article we detail the expert-vetted, rules-based approach to standardizing line of therapy capture for #oncologyresearch. This standardized foundation enables researchers to proceed directly to analysis with confidence. Read now: tempus.co/4aiujMi
So proud to see two of the top pharmaceutical CEOs in the world, Pascal Soriot, CEO of @AstraZeneca, and Rob Davis, CEO of @Merck, recently highlight their strategic partnerships with Tempus to bring the power and promise of artificial intelligence to oncology. bit.ly/4ofFHOF bit.ly/4vBGgVD
Our single, research-ready dataset gives you a complete picture by unifying connected clinical histories, rich multimodal biology, and a representative patient population. Assess your cohort’s feasibility with our RWD by submitting your preliminary criteria, and our team will provide a tailored feasibility assessment to help accelerate your research goals: tempus.co/4uduyzn
#ASCO26 has come to a close and we're grateful for an impactful weekend in Chicago spent with colleagues and the greater oncology community. Check out some highlights below, including the presentations of our largest collection of accepted research to date, an engaging Industry Expert Theater, and four days of conversations and demos at our booth. You can find more information about our presence at ASCO here: tempus.co/3RZyVAD
Together with @YNHH and @MSKCancerCenter, we are pleased to announce the launch of a digital pathology IMS Open-Source Consortium. Designed to accelerate the democratization and standardization of digital pathology, the consortium aims to bring together leading academic medical centers and industry partners to develop a best-in-class open-source digital pathology platform and viewer. Read on: tempus.co/3PCH7WY
We're excited to announce the upcoming clinical availability of xH, a next-generation sequencing test that uses a whole-genome sequencing approach for the detection of actionable oncologic targets in peripheral blood and bone marrow samples from patients with hematologic malignancies. Data presented at #ASCO26 demonstrate the assay's clinical utility in resolving historical diagnostic blind spots. Learn more: tempus.co/4o1YTQ5
Meet the next-generation of Lens, our pioneering agentic AI platform designed to accelerate drug development and research. Specialized tools include: ▪️ Custom Research Plan Generation ▪️ On-Demand Execution ▪️ Specialized AI Agents ▪️ Reproducible Intelligence Read on: tempus.co/3RxmUCu
Test selection matters, esp in genomics - HLA can be tested in tumor, blood with different mechanisms for false - and + ➡️high tumor purity and LOH lead to most false - ➡️blood sometimes needed when tumor QC is low at locus of interest ➡️bioinformatics algos matter #ASCO26
We're excited to share the launch of the PRECISION Challenge: a national initiative engineered to accelerate the next generation of oncology breakthroughs leveraging its foundational model. The PRECISION Challenge aims to unlock breakthroughs in oncology at scale by providing access to data, funding, and expertise to multidisciplinary teams around the world who seek to make bold advances in cancer treatment and improve patient outcomes. We will announce the opening of applications for the inaugural cohort in the coming months. Learn more: tempus.co/4dSHNPX #ASCO26
#ASCO26: Don't miss our Industry Expert Theater this afternoon in Theater 2, Exhibit Hall A from 3:00 pm – 4:00 pm CT. Our Chief Scientific Officer, Kate Sasser, PhD, will join our Chief Medical Officer, Ezra Cohen, MD to explore how our comprehensive diagnostic intelligence platform transforms vast datasets into insights to ensure that no patient is left behind in the pursuit of better outcomes.
Introducing Tempus Preview: an application providing rapid, clinically significant insights that close the gap between the time of order and delivery of insights. Representing a significant paradigm shift in precision oncology workflows, Tempus Preview offers preliminary results in the critical window between when a diagnostic test is ordered and when final sequencing results are delivered by surfacing key mutation predictions within approximately 24 hours of tissue receipt. Learn more: tempus.co/3PUFnYZ #ASC026
Thank you to all who joined us today. The full recording and presentation deck are now available: edge.media-server.com/mmc/p/xtnkvqcb/ #TEMInvestorDay
REMINDER: Join us this morning for #TEMInvestorDay with the Tempus leadership team and presentations from the our Diagnostics and Data & Applications organizations. The event begins at 8:00 a.m. CT / 9:00 a.m. ET and can be streamed here: edge.media-server.com/mmc/p/xtnkvqcb/
We're proud to announce that the U.S. Food and Drug Administration (FDA) has granted approval for a tumor-only indication for our xT CDx next-generation sequencing platform. With this expanded label, Tempus is the first laboratory to hold FDA companion diagnostic (CDx) approval for both tumor-only and tumor-normal comprehensive genomic profiling. Read on: tempus.co/4eaJ9Xr #ASCO26 *xT CDx is a qualitative Next Generation Sequencing (NGS)-based in vitro diagnostic device intended for use in the detection of substitutions (single nucleotide variants (SNVs) and multi-nucleotide variants (MNVs)) and insertion and deletion alterations (INDELs) in 648 genes in patients with previously diagnosed solid malignant neoplasms. The assay uses DNA isolated from Formalin-Fixed Paraffin Embedded (FFPE) tumor tissue specimens and, when available, patient-matched blood or saliva specimens. Additionally, the device detects microsatellite instability (MSI) status based on a genomic signature from the tumor specimen only. The test is intended as a companion diagnostic (CDx) to identify patients who may benefit from treatment with the targeted therapies listed in the Companion Diagnostic Indications table in accordance with the approved therapeutic product labeling. Additionally, xT CDx is intended to provide tumor mutation profiling to be used by qualified health care professionals in accordance with professional guidelines in oncology for patients with previously diagnosed solid malignant neoplasms. Genomic findings other than those listed in the Companion Diagnostic Indications table are not prescriptive or conclusive for labeled use of any specific therapeutic product.
As a primary proof of concept, Tempus' model was utilized to analyze EGFR-mutant NSCLC patients treated with osimertinib, the current frontline standard of care third-generation EGFR-inhibitor. We assessed whether the model could accurately stratify response to the standard of care treatment of osimertinib in patients with known clinically actionable biomarkers like EGFR. Without any pre-specified training, the model demonstrated: ▪️ Predictive Accuracy: A C-index of 0.802 for overall survival (p value < 0.001). ▪️ Significant Survival Stratification: Hazard Ratio of 4.536 (95% CI: [3.289, 6.255]) between high- and low-risk subgroups. Read on: tempus.co/3RU6vIh #ASCO26
Today we shared announced initial results from our Multimodal Foundation Models for oncology, which leverage over 500 petabytes of patient data to accurately predict patient outcomes and deliver novel insights for precision medicine and drug development. Read here: tempus.co/4nUv3wV #ASCO26
REMINDER: Join us this morning for #TEMInvestorDay with the Tempus leadership team and presentations from the our Diagnostics and Data & Applications organizations. The event begins at 8:00 a.m. CT / 9:00 a.m. ET and can be streamed here: edge.media-server.com/mmc/p/xtnkvqcb/
We're excited to announce a significant expansion of new indications to Next, our AI-enabled platform, establishing a new category of "real-time clinical intelligence" — a departure from legacy retrospective analyses and generic EHR alerts — designed to facilitate the delivery of precision medicine. To demonstrate the real-world impact of these expanded capabilities, we are presenting a landmark study at #ASCO26: "Multi-center prospective study evaluating an AI-enabled clinical decision support tool to improve biomarker testing in early-stage NSCLC," on May 31 from 9:00 am – 12:00 pm CT. (Poster #518) Learn more: tempus.co/3RSbx89
We're proud to announce that 37 abstracts have been accepted for presentation at #ASCO26, marking our largest collection of accepted research to date. These findings demonstrate the critical role that multimodal data and AI-driven insights play in advancing precision medicine across oncology. Swipe through some highlights below and the full scope of Tempus-authored research here: tempus.co/4ecfAE3
Mark Lewis, MD, FASCO @marklewismd
96K Followers 35K Following Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.
Vivek Subbiah, MD @VivekSubbiah
41K Followers 2K Following Drug Development| Precision Oncology| Tissue-Agnostic Precision Medicine #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Anirban Maitra @Aiims1742
33K Followers 3K Following Pancreatic cancer researcher, GI pathologist, husband, dad. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Pashtoon Kasi MD, MS @pashtoonkasi
20K Followers 14K Following Oncologist |Researcher| ColorectalCancer #CRCSM👨🏼🎓@MayoClinic @PittTweet Alum 🧬#ctDNA #LiquidBiopsies #PrecisionOncology @CityOfHope Views my own-COI @ASCO
Atul Butte @atulbutte
29K Followers 4K Following Chief Data Scientist @UofCAHealth・Director, Bakar Computational Health Sci Institute @UCSF_BCHSI・Distinguished Prof @UCSF・Entrepreneur・He/him・Opinions ⇨ my own
Anshul Kundaje @anshulkundaje
31K Followers 3K Following Federally funded academic research is the innovation engine of the US economy. Reform is welcome. Destruction will have long term consequences.
Pranav Rajpurkar @pranavrajpurkar
27K Followers 799 Following Co-Founder a2z Radiology AI https://t.co/mdi996SFZy | Assistant Professor Harvard Lab: https://t.co/Z6tBGoluEG
Veera Rajagopal @doctorveera
21K Followers 5K Following 🇮🇳 MBBS, MD, 🇩🇰 PhD | 🧬 Co-founder & CSO @wellytics Building genetics-driven drug discovery in India Thoughts: https://t.co/QKUXWuTGfr
Lurie Cancer Center @LurieCancer
10K Followers 6K Following Cancer program @NorthwesternMed. Northwestern Memorial Hospital is among top 2% of hospitals in the nation for cancer by U.S. News & World Report, 2025 – 2026.
Roxana Daneshjou MD/P... @RoxanaDaneshjou
22K Followers 5K Following Assistant professor of Biomedical Data Science @StanfordDBDS and Dermatology @StanfordMed | AI/ML & precision health | @Rice_BioE alum | @pdsoros Fellow 2014
Chris Gibson @RecursionChris
9K Followers 1K Following Father/Husband/Scientist/Co-Founder & Chair $RXRX, “OG of TechBio,” Boards: @pacbio @cellinobio @sltrib @biohiveutah - TechBio/cars/musings/typos/opinions
Personalis, Inc. @PersonalisInc
3K Followers 1K Following Personalizing Precision Oncology #PrecisionOncology | #ImmunoOncology | #ImmunoGenomics | #Biomarkers | #TumorMicroenvironment | #Exome | #Transcriptome
Recursion @RecursionPharma
17K Followers 770 Following Decoding biology to radically improve lives. The industrial revolution of drug discovery is here.
PanCAN @PanCAN
27K Followers 6K Following Our vision is to create a world in which all patients with pancreatic cancer will thrive. 💜
Craig Horbinski @CraigHorbinski
13K Followers 3K Following Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic Florida. My #NIH-funded laboratory studies #glioma and #meningioma.
Charles Roberts @CCRobertsARK
59K Followers 3K Following Chief Investment Strategist, Private Equity @ARKInvest; techbio cofounder: AI/omics unicorn Freenome, Relation Tx. Disclosure: https://t.co/EueoFlXwoI
Gene Solutions @GS_bio
0 Followers 15 Following Gene Solutions is an international biotechnology company headquartered in Singapore. We provide a comprehensive genetic testing portfolio powered by NGS and AI
Earthling @Satoshi_Cat
316 Followers 1K Following earthling ⚡ noise, light & other strange transmissions Frequency Unknown. Gen X #TechForGood.
Cyhangin @cyhungin_y
102 Followers 357 Following
Hang Li @HangLi480353
0 Followers 70 Following
brano 82 @82Brano64722
18 Followers 53 Following
Dangerr @dangerrre
82 Followers 503 Following
Stefano Martano @martano_ste
2 Followers 20 Following Cardiologist ❤️🩹 Building the next healthcare unicorn
Tommaso Landolfo @TommasoLandolf3
15 Followers 103 Following
Jack Rose @JackRose1145199
220 Followers 500 Following
Andrei Bogdan @ndrbgdn
3 Followers 132 Following
Mostfa Ahmed @MostfaAhme18954
0 Followers 12 Following
CosmoDoctor @Cosmodoctor_
157 Followers 968 Following l play poker with chess players! amplify conspiracies!
Iñigo Ruiz crespo fe... @inigoruiiz_
29 Followers 243 Following
QPOANOO @qpoanoo
0 Followers 60 Following
Jenny Han @jennyjwh
42 Followers 58 Following
Ferran Paüls Vergés @PaulsFerran
221 Followers 2K Following
Skeptical Stoic @StoicSkeptic
10K Followers 9K Following We can no longer attribute to chronic incompetence that which can be adequately explained by calculated malice. Amor Fati. Σ
Sean O'Connell @SeanocoSean
206 Followers 1K Following
Gift From God @MartEnterprises
5K Followers 1K Following @GrindHouseCap Investor | Trading | BYB | Fintech Sales | If you wanna learn how to make more money💰holla at me!
juan camilo @THOMASM2011
8 Followers 339 Following
ryan van der veer @sumbios
1K Followers 2K Following Public equities since 2019 — Systems Engineering, Policy Analysis and Management @TPMTUDelft
0407 @A20240407
345 Followers 2K Following
Brian Feller @bfells5
116 Followers 1K Following
Angela @LatitudeAlpha
20 Followers 92 Following Managing Trustee, Latitude Alpha Trust. Digital infrastructure at the convergence of healthcare, security and revenue AI. https://t.co/WHUCl9BQEK
johnyu @WAMMJOH
1 Followers 34 Following
Kim Column @wangyi81944839
1 Followers 110 Following
Palak Patel @palakspatel
8K Followers 2K Following Chief Content Officer, Prime Focus Studios DNeg. Movie Producer: The Gray Man, Maleficent, Snow White and the Huntsman, Oz The Great And Powerful. Investor. 🦅
Sonit Sai Vasipalli @sonit_sai
42 Followers 376 Following MBBS (M4) @OfficialJipmer | Research @KCDH_A | AI/ML and Digital Health
Dhruv Hemmady @DhruvHemmady
418 Followers 5K Following
Mr Y @Yjyyyyyyw
3 Followers 74 Following
Ander @Macaleleo
8K Followers 8K Following 📢 ATTENTION, APPLE EMPLOYEES! This is a call to YOU! I’m proposing an idea that will take Apple to a WHOLE NEW LEVEL! 🚀 Don’t miss this opportunity! PLEASE 🚀
Chris @Chrisa2jf
6 Followers 77 Following
Niels Rocheblanche @N_Rocheblanche
24 Followers 98 Following Le marché récompense la patience. Trader | Investisseur
Desert Warrior @Desertwarrior89
40 Followers 257 Following
K han 🐎 @KhanOverlord
299 Followers 3K Following
Adam Thiesen @adam_thiesen
3K Followers 2K Following Focus does not shrink the world by making it less vast, but by revealing how closely everything is connected.
Amos Chan @AmosChan20735
1 Followers 25 Following
Anand Prakash @anandpraka_sh
11K Followers 793 Following Founder & CEO, @pingsafeai (Acquired by SentinelOne), Top ranked whitehat hacker on Twitter, Uber, LinkedIn, Meta , ex-flipkart
Alisha Maity @AlishaMaity
264 Followers 601 Following Heme-Onc fellow | Philly | @mainlinehealth | @JeffersonUniv #JeffVotes | @Columbia | @baldwinschool
Mark Lewis, MD, FASCO @marklewismd
96K Followers 35K Following Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.
Brad Loncar @bradloncar
82K Followers 367 Following #Biotech, Founder of @BiotechTV, KC native, @univmiami hurricane.🧬🙌
Anirban Maitra @Aiims1742
33K Followers 3K Following Pancreatic cancer researcher, GI pathologist, husband, dad. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Toni Choueiri, MD @DrChoueiri
45K Followers 348 Following Chief GU Cancers @DanaFarber II Prof Medicine @HarvardMed II ⚽ lover II @PanMass 🚲rider.
Pashtoon Kasi MD, MS @pashtoonkasi
20K Followers 14K Following Oncologist |Researcher| ColorectalCancer #CRCSM👨🏼🎓@MayoClinic @PittTweet Alum 🧬#ctDNA #LiquidBiopsies #PrecisionOncology @CityOfHope Views my own-COI @ASCO
chadi nabhan MD, MBA,... @chadinabhan
21K Followers 922 Following Heme/Onc; NHL/HL/CLL. Adj Professor U of SC; Host: the #HealthcareUnfiltered podcast. Author of "TOXIC EXPOSURE" & “THE CANCER JOURNEY.” 3rd book out in 2026.
Paolo Tarantino @PTarantinoMD
32K Followers 788 Following MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. Associate Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
Christina Farr @chrissyfarr
96K Followers 3K Following Second Opinion Media CEO, writing about the future of healthcare. GP @ Scrub Capital. Host of Lifers. Mama. Opinions my own.
Stephen V Liu, MD @StephenVLiu
30K Followers 4K Following Thoracic Oncology, Chief of Heme/Onc @Georgetown @MedStarGUH, Head of Developmental Therapeutics @LombardiCancer, #DCLung26 #TexasLung27 #HereWeGo #LetsGoBucs
Atul Butte @atulbutte
29K Followers 4K Following Chief Data Scientist @UofCAHealth・Director, Bakar Computational Health Sci Institute @UCSF_BCHSI・Distinguished Prof @UCSF・Entrepreneur・He/him・Opinions ⇨ my own
Dr. Anthony Letai @NCIDirector
32K Followers 1K Following Official account of Anthony Letai, M.D., Ph.D. Director of @theNCI from 9/29/25. Engagement ≠ endorsement. Privacy: https://t.co/AxsApipkIb
OncLive.com @OncLive
50K Followers 2K Following Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
SABCS @SABCSSanAntonio
16K Followers 707 Following An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer
Stephanie Graff, MD, ... @DrSGraff
22K Followers 4K Following Director Breast Oncology, Brown University Health | Assoc Prof Legorreta Cancer Center Brown Univ | Views Mine | https://t.co/WVUQaIHeKn | COI ⬇
UT MD Anderson @UTMDAnderson
142K Followers 4K Following Official account of The University of Texas MD Anderson Cancer Center. Our mission is to #EndCancer through patient care, research, education & prevention.
David Steensma, MD @DavidSteensma
27K Followers 454 Following Hematologist-oncologist. @AjaxThx CMO. Former Edward P. Evans Chair in MDS @DanaFarber, @HarvardMed & @MayoClinic faculty, @NovartisScience hematology head.
Blake Madden 🏥 @B_Madden4
19K Followers 1K Following I break down the $5.3T business of healthcare after working on the inside. Essays on strategy, M&A, finance, health tech, & more. Texas ex
ASCO @ASCO
151K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Signal: MattHerper.92
The ASCO Post @ASCOPost
62K Followers 4K Following News and views from the world of clinical oncology and hematology
Daiichi Sankyo US @DaiichiSankyoUS
4K Followers 382 Following We create life-changing solutions for patients. See our guidelines: https://t.co/A1iZajC0s5
Heart of Healthcare P... @hoh_pod
22K Followers 113 Following 🏆 #1 podcast in the Top 100 Health Tech All time charts 👥 Hosted by digital health veterans @halletecco @stephenkraus @mtesquivel 🎙 New episode every Monday
Nature Portfolio @NaturePortfolio
2.1M Followers 2K Following Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
Katie Greifeld @kgreifeld
114K Followers 2K Following markets & macro @business, anchor of The Close (3-5pm daily) and ETF IQ (12pm Mondays) @bloombergtv. money stuff podcast co-host. ktkaos on Insta.
HeartRhythm @hrs_journal
22K Followers 31 Following Heart Rhythm, the official Journal of the HRS, CES, and PACES, is a unique journal for fundamental discovery & clinical applicability in electrophysiology.
World ADC @World_ADC
866 Followers 740 Following Official account for World ADC Event Series #WorldADC
Annabel Burba @annieburba
153 Followers 76 Following reporting on the creator economy for @Inc | subscribe to Founder Focus here: https://t.co/pgTyEd5ywi
Rolfe Pancreatic Canc... @RolfeFoundation
1K Followers 3K Following Providing personal support to those affected by #PancreaticCancer through tailored resources, connections & education, & funding for #EarlyDetection research.💜
Mercy @FollowMercy
7K Followers 1K Following Mercy serves millions with quality care across 55 hospitals, 1,000+ clinics and $500M+ in free care and community benefits in FY25.
Global Cancer Institu... @theGCI
352 Followers 148 Following Committed to improving the survival and quality of life of underserved cancer patients worldwide.
TIME @TIME
18.5M Followers 474 Following News and current events from around the globe. Since 1923. Subscribe: https://t.co/yT0dueLEm0
Shalene Gupta @ShaleneGupta
3K Followers 1K Following staff editor @FastCompany The Power of Trust | The Cycle Rep @abwycisk & @PeterWBernstein Speaking @sternstrategy 🇨🇳-🇮🇩&🇮🇳 MN grown PMDD
Mercy Health @mercy_health
8K Followers 675 Following Mercy Health is a Catholic health care ministry serving Ohio and Kentucky. View our social media community guidelines here: https://t.co/G0NJL9JIj9.
Bruce Japsen @brucejapsen
13K Followers 2K Following Senior Contributor @Forbes. Talking healthcare & biz @WBBMNewsradio @forbesonfox. Author: Inside Obamacare & Walmart's 2nd Opinion. Adjunct @UIOWA_SJMC. Hawkeye
Brian Sozzi @BrianSozzi
42K Followers 5K Following Executive Editor @YahooFinance. Host of the 'Power Players' podcast. Prior Life: Exec. Editor @TheStreet + Stock Analyst. No stopping. No excuses. 💪
AHN @AHNtoday
11K Followers 1K Following We’re a 14 hospital health system dedicated to providing exceptional care in PA and NY. 👩⚕️💚👨⚕️ We're proud to be part of Highmark Health.
SWOG Cancer Research ... @SWOG
15K Followers 1K Following SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.
Brian Eisenmenger @Eisenmengercpas
191 Followers 147 Following CPA and frequent speaker on tax and estate planning issues throughout the United States.
Abrams Research Cente... @ARC_Neuro
71 Followers 853 Following The ARC at Northwestern University is dedicated to advancing Alzheimer’s disease research with sophisticated genomics tools and AI analytics.
Journal for ImmunoThe... @jitcancer
10K Followers 2K Following The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD
Robert Langreth @RobertLangreth
7K Followers 356 Following Science and health reporter at large, Bloomberg News
MPN_Hub @MPN_Hub
3K Followers 873 Following A global online platform providing the latest treatment options and medical information on myeloproliferative neoplasms (MPN) https://t.co/i05G5CxM3P #mpnsm
Kate Knibbs 🏄🏻�... @Knibbs
16K Followers 3K Following senior writer at Wired 🦐 Story tips: [email protected] (or DM me for Signal/WhatsApp!) extremeknibbs on Insta/Threads and @knibbs.bsky.social
Harry McCracken @harrymccracken
83K Followers 5K Following Former Twitter user. Where to find me now: https://t.co/85a9dzDbTo
ISPOR @ISPORorg
11K Followers 281 Following ISPOR is the leading global scientific and educational organization for health economics and outcomes research (#HEOR). Retweets do not equal endorsements
The Journal of Molecu... @JMDiagn
3K Followers 342 Following The official publication of the Association for Molecular Pathology @AMPath, co-owned by the American Society for Investigative Pathology @ASIPath.
AACR President Keith ... @AACRPres
5K Followers 8 Following @AACR President (2026-2027). Director of clinical cancer research, Mass General Cancer Center; professor, Harvard Medical School. Follows/RTs ≠ endorsements.
Jordyn Holman @JordynJournals
18K Followers 3K Following Reporter @nytimes • Writer of “Corner Office” • Busy reading some book • Chicagoan forever • [email protected]
Gina Chon @GinaChon
5K Followers 482 Following Senior Editor @Semafor in DC. Covered M&A, Iraq war, economy, Khmer Rouge and cars. Formerly of Reuters Breakingviews, FT, Quartz, WSJ. [email protected]
Sharon Goldman @sharongoldman
8K Followers 3K Following Reporter on the AI beat, @FortuneMagazine [email protected]
AJMC @AJMC_Journal
7K Followers 890 Following The American Journal of #ManagedCare is a peer-reviewed, indexed publication. https://t.co/I2WRhmhOVC offers news in health policy, disease states, and managed care.
Torie Bosch @thekibosch
5K Followers 3K Following First Opinion editor, First Opinion Podcast host, @STATNews Formerly @Slate, @ASU, @NewAmerica, @FutureTenseNow, @StateMindSlate, @TheOpenNotebook
NextMed Health @NextMedHealth
26K Followers 3K Following https://t.co/tFoCDLKAzu is a cross-disciplinary program & community from across #healthtech & biomedicine reimagining the future of health & biomedicine.
Oncology Central @OncologyCentral
5K Followers 4K Following Oncology Central, part of Taylor and Francis, is the online resource for #oncology professionals.
Digital Health New Yo... @DigitalHealthNY
341 Followers 260 Following DHNY delivers exceptional experiences, events and opportunities to unite the digital health community in New York.
Deep 6 AI @deep6ai
1K Followers 2K Following Deep 6 AI finds patients for clinical trials in minutes, not months, getting life-saving cures to patients faster #clinicaltrials #artificialintelligence #AI
Ed Stapley @estapley
200 Followers 2K Following Senior Editor, Bloomberg New Economy | Arsenal enthusiast | Opinions belong to me
Scottish Mortgage Inv... @ScotMortgage_UK
1K Followers 358 Following Owning the world's top growth companies. For UK investors and professional investors in Benelux, Germany, Switzerland, Hong Kong and Singapore.
Anna Tong @annatonger
8K Followers 1K Following @Forbes reporter covering artificial intelligence and technology. Signal: 6504683913 / [email protected]
Krishan Jethwa @KrishanJethwa
4K Followers 1K Following GI Radiation Oncologist | Associate PD @MayoRadOnc @MayoClinic | Passions for #PatientCare, #MedEd, QoL, #PublicHealth, and #ClinicalTrials | Views are my own
Personalis, Inc. @PersonalisInc
3K Followers 1K Following Personalizing Precision Oncology #PrecisionOncology | #ImmunoOncology | #ImmunoGenomics | #Biomarkers | #TumorMicroenvironment | #Exome | #Transcriptome
Amy Feldman @amyfeldman
11K Followers 4K Following Senior editor at @Forbes. Find me on Bluesky or LinkedIn.
Alexis Kramer @alexis_s_kramer
1K Followers 2K Following East Coast Editor at @Bisnow. Past: @BLaw veteran; @endpts. Artist, Snowboarder, Tennis Player. Tweets are my own, retweets not endorsements.
Rowan Cheung @rowancheung
591K Followers 563 Following Founder of the world’s most read daily AI newsletter @therundownai. Sharing the latest developments in the world of artificial intelligence.
Nasdaq Exchange @NasdaqExchange
776K Followers 9K Following Home to the world's most innovative companies. #NasdaqListed
Richard Nieva @richardjnieva
7K Followers 2K Following Senior writer, @Forbes, covering AI. Previously: @BuzzFeedNews. East Bay native. DMs open. Tips: [email protected] or Signal at username RNieva.26














